BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18647414)

  • 21. Heterologous Boost Following
    Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
    Front Immunol; 2018; 9():2439. PubMed ID: 30425711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine.
    Wu M; Li M; Yue Y; Xu W
    Microbiol Immunol; 2016 Sep; 60(9):634-45. PubMed ID: 27531823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenylate kinase: a novel antigen for immunodiagnosis and subunit vaccine against tuberculosis.
    Xiao Y; Sha W; Tian Z; Chen Y; Ji P; Sun Q; Wang H; Wang S; Fang Y; Wen HL; Zhao HM; Lu J; Xiao H; Fan XY; Shen H; Wang Y
    J Mol Med (Berl); 2016 Jul; 94(7):823-34. PubMed ID: 26903285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
    Gao H; Li K; Yu S; Xiong S
    Microbiol Immunol; 2009 Oct; 53(10):541-9. PubMed ID: 19780967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a novel vaccine (HVJ-liposome/HSP65 DNA+IL-12 DNA) against tuberculosis using the cynomolgus monkey model of TB.
    Okada M; Kita Y; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Fukamizu R; Tsunai Y; Inoue R; Nakatani H; Namie Y; Yamada J; Takao K; Asai R; Asaki R; Matsumoto M; McMurray DN; Dela Cruz EC; Tan EV; Abalos RM; Burgos JA; Gelber R; Sakatani M
    Vaccine; 2007 Apr; 25(16):2990-3. PubMed ID: 17280753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis.
    Derrick SC; Perera LP; Dheenadhayalan V; Yang A; Kolibab K; Morris SL
    Vaccine; 2008 Nov; 26(48):6092-8. PubMed ID: 18809446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incorporation of immunostimulatory motifs in the transcribed region of a plasmid DNA vaccine enhances Th1 immune responses and therapeutic effect against Mycobacterium tuberculosis in mice.
    Wu J; Ma H; Qu Q; Zhou WJ; Luo YP; Thangaraj H; Lowrie DB; Fan XY
    Vaccine; 2011 Oct; 29(44):7624-30. PubMed ID: 21856352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccine adjuvant: it makes the difference.
    Lima KM; dos Santos SA; Rodrigues JM; Silva CL
    Vaccine; 2004 Jun; 22(19):2374-9. PubMed ID: 15193397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel prophylactic vaccine using a prime-boost method and hemagglutinating virus of Japan-envelope against tuberculosis.
    Okada M; Kita Y; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Nakatani H; Takao K; Kishigami C; Nishimatsu S; Sekine Y; Inoue Y; McMurray DN; Sakatani M
    Clin Dev Immunol; 2011; 2011():549281. PubMed ID: 21437226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-mediated immune responses and protective efficacy against infection with Mycobacterium tuberculosis induced by Hsp65 and hIL-2 fusion protein in mice.
    Shi C; Yuan S; Zhang H; Zhang T; Wang L; Xu Z
    Scand J Immunol; 2009 Feb; 69(2):140-9. PubMed ID: 19144078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective efficacy of different strategies employing Mycobacterium leprae heat-shock protein 65 against tuberculosis.
    Souza PR; Zárate-Bladés CR; Hori JI; Ramos SG; Lima DS; Schneider T; Rosada RS; Torre LG; Santana MH; Brandão IT; Masson AP; Coelho-Castelo AA; Bonato VL; Galetti FC; Gonçalves ED; Botte DA; Machado JB; Silva CL
    Expert Opin Biol Ther; 2008 Sep; 8(9):1255-64. PubMed ID: 18694348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved cellular immune response elicited by a ubiquitin-fused ESAT-6 DNA vaccine against Mycobacterium tuberculosis.
    Wang QM; Kang L; Wang XH
    Microbiol Immunol; 2009 Jul; 53(7):384-90. PubMed ID: 19563397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo electroporation of a codon-optimized BER
    Tang J; Cai Y; Liang J; Tan Z; Tang X; Zhang C; Cheng L; Zhou J; Wang H; Yam WC; Chen X; Wang H; Chen Z
    Tuberculosis (Edinb); 2018 Dec; 113():65-75. PubMed ID: 30514515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming.
    Gonçalves ED; Bonato VL; da Fonseca DM; Soares EG; Brandão IT; Soares AP; Silva CL
    Genet Vaccines Ther; 2007 Aug; 5():7. PubMed ID: 17714584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycobacterium hsp65 DNA entrapped into TDM-loaded PLGA microspheres induces protection in mice against Leishmania (Leishmania) major infection.
    Coelho EA; Tavares CA; Lima Kde M; Silva CL; Rodrigues JM; Fernandes AP
    Parasitol Res; 2006 May; 98(6):568-75. PubMed ID: 16432754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative evaluation of intranasal and subcutaneous route of immunization for development of mucosal vaccine against experimental tuberculosis.
    Giri PK; Sable SB; Verma I; Khuller GK
    FEMS Immunol Med Microbiol; 2005 Jul; 45(1):87-93. PubMed ID: 15985227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCG constitutively expressing the adenylyl cyclase encoded by Rv2212 increases its immunogenicity and reduces replication of M. tuberculosis in lungs of BALB/c mice.
    Pedroza-Roldán C; Marquina-Castillo B; Mata-Espinosa D; Barrios-Payán J; Aceves-Sánchez MJ; Hernández Pando R; Flores-Valdez MA
    Tuberculosis (Edinb); 2018 Dec; 113():19-25. PubMed ID: 30514503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.
    Dai G; Rady HF; Huang W; Shellito JE; Mason C; Ramsay AJ
    Vaccine; 2016 Dec; 34(50):6267-6275. PubMed ID: 27823900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a temperature-restricted, mucosal tuberculosis vaccine in guinea pigs.
    Gupta T; LaGatta M; Helms S; Pavlicek RL; Owino SO; Sakamoto K; Nagy T; Harvey SB; Papania M; Ledden S; Schultz KT; McCombs C; Quinn FD; Karls RK
    Tuberculosis (Edinb); 2018 Dec; 113():179-188. PubMed ID: 30514501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.